Clinical Roundup Phase II OVATION 2 Study of IMNN-001 shows positive OS for ovarian cancer December 13, 2024Vol.50 No.46
Clinical Roundup Hair growth drug safe at low doses for breast cancer patients December 13, 2024Vol.50 No.46
Clinical Roundup Monoclonal antibody improves survival in cancer-associated hyper-inflammatory disorder December 13, 2024Vol.50 No.46
Clinical Roundup HIFU demonstrates positive outcomes in management of prostate cancer, study shows December 13, 2024Vol.50 No.46
Clinical Roundup “Biological age” may predict early colorectal cancer risk December 13, 2024Vol.50 No.46
Clinical Roundup Repurposed drug has promising efficacy in shrinking NSCLC tumors December 13, 2024Vol.50 No.46
Clinical Roundup Blood test predicts prognosis for advanced prostate cancer, study finds December 13, 2024Vol.50 No.46
Clinical Roundup Study identifies that higher West African ancestry may contribute to worse outcomes December 13, 2024Vol.50 No.46
Drugs & Targets MD Anderson, AmMax Bio announce agreements to develop immunotherapy for MRD-positive cancers December 13, 2024Vol.50 No.46
